Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FK921
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,076
Award facts
- Contract value 100% obligated
- $34,076.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,076.25 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
BIKTARVY is an antiretroviral medication used in the treatment of HIV. This delivery order exemplifies the routine pharmaceutical procurement conducted by DLA Medical Supply Chain to support military treatment facilities and veterans' healthcare programs. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical vendor, regularly fulfills such orders across multiple therapeutic domains through its comprehensive IDC with the Defense Logistics Agency, demonstrating the company's capability to efficiently meet government requirements for essential prescription medications and medical commodities.
Quick answers
Who was awarded contract SPE2DR26FK921?
SPE2DR26FK921 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FK921 worth?
The government has obligated $34,076 on SPE2DR26FK921.
Is contract SPE2DR26FK921 an order under another contract?
Yes. SPE2DR26FK921 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK921 competed?
The extent of competition for SPE2DR26FK921 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award